These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 19535691

  • 1. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M, Levy JH, Tanaka KA, Ramsay JG.
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [Abstract] [Full Text] [Related]

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 4. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A, Mateo J, Oliver A, Litvan H, Murillo J, Souto JC, Fontcuberta J.
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [Abstract] [Full Text] [Related]

  • 5. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM, Jackson LR, Chatwin C, Smolich JJ.
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [Abstract] [Full Text] [Related]

  • 6. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P, Alfieri O, D'Angelo A.
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of the effects of epsilon-aminocaproic acid and aprotinin on intra- and postoperative bleeding in heart surgery].
    Trinh-Duc P, Wintrebert P, Boulfroy D, Albat B, Thévenet A, Roquefeuil B.
    Ann Chir; 1992 Jul; 46(8):677-83. PubMed ID: 1283661
    [Abstract] [Full Text] [Related]

  • 8. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 9. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.
    Greilich PE, Brouse CF, Whitten CW, Chi L, Dimaio JM, Jessen ME.
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1498-503. PubMed ID: 14666025
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M.
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [Abstract] [Full Text] [Related]

  • 11. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
    Royston D, Levy JH, Fitch J, Dietrich W, Body SC, Murkin JM, Spiess BD, Nadel A.
    Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936
    [Abstract] [Full Text] [Related]

  • 12. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ, Nielsen C.
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [Abstract] [Full Text] [Related]

  • 14. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenperä M.
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [Abstract] [Full Text] [Related]

  • 15. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
    Cicekcioglu F, Cagli K, Emir M, Topbas M, Catav Z, Sener E, Tasdemir O.
    J Card Surg; 2006 Oct; 21(4):336-41. PubMed ID: 16846409
    [Abstract] [Full Text] [Related]

  • 16. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF, Faghih F, Greenberg CS, Leslie JB, Sladen RN.
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [Abstract] [Full Text] [Related]

  • 17. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ, Legnani C, Groenland TH, Palareti G, Begliomini B, Terpstra OT, Porte RJ.
    Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
    [Abstract] [Full Text] [Related]

  • 18. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC, Reames MK, Skipper E, Stiegel RM, Nussbaum M, Geller R, Robicsek F, Lobdell KW.
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [Abstract] [Full Text] [Related]

  • 19. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J, Lindvall G, Sartipy U.
    Circulation; 2005 Aug 30; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery.
    Sharma V, Talwar S, Choudhary SK, Lakshmy R, Kale S, Kumar AS.
    Heart Lung Circ; 2006 Aug 30; 15(4):261-5. PubMed ID: 16698318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.